Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Pombiliti 105 mg powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
cipaglucosidase alfa
Company:  
Amicus Therapeutics UK Ltd See contact details
ATC code: 
A16AB23
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Cipaglucosidase Alfa Home Infusion Patient Diary

Supplementary Home Infusion Patient Diary

{pdf_link}

Cipaglucosidase Alfa Home Infusion Patient Manual

Home Infusion Patient Manual

{pdf_link}

Patient Reminder Card for Pombiliti (cipaglucosidase alfa) + Opfolda (miglustat) for women of childbearing potential

Patient reminder card

{pdf_link}

Pombiliti (Cipaglucosidase Alfa) + Opfolda (Miglustat) Information Pack For Healthcare Professionals

Information Pack For Healthcare Professionals

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Amicus Therapeutics UK Ltd
Company image
Address
One Globeside, Fieldhouse Lane, Marlow, SL7 1HZ
Telephone
+44 01753 888 567
Medical Information Direct Line
08082346864
Medical Information e-mail
[email protected]
WWW
http://www.amicusrx.co.uk